Â
R. Markovic et al. / Tetrahedron 57 $2001) 5833±5841
5839
*2c) was carried out using the product obtained after isomer-
ization in ethanol *ratio 2Z,5Z/2E,5Z89/11): mp 166±
1678C; IR *KBr) nmax 3193, 3079, 1727, 1616, 1550,
JBX4.9 Hz, CHAHBCHXS), NCH2 signal not visible, 4.09
*2H, q, J7.2 Hz, CH2O), 4.27*1H, dd, JAX7.3 Hz,
JBX4.9 Hz, CHXS), 7.16±7.34 *5H, m, Ph), 7.77 *1H, t,
J5.7Hz, NH exo), 11.02 *1H, s, NHring).
1467, 1421, 1402, 1220, 1046, 862,762, 707, 651 cm21
;
1H NMR *CDCl3): d 1.37*3H, t, J7.1 Hz, CH3), 4.34
*2H, q, J7.1 Hz, CH2O), 6.91 *or 6.95) *1H, s, vC*20)),
6.95 *or 6.91) *1H, s, vCH*50)), 7.42±7.61 *3H, m, m- and
p-Ph), 7.94±7.97 *2H, d, o-Ph) 9.70 ppm *1H, s, NH ring);
13C NMR *CDCl3): d 14.2 *CH3), 61.7*CH 2O), 98.0
*vC*20), 118.7* vC*50), 127.8 *o-Ph), 128.8 *m-Ph),
132.9 *p-Ph), 137.6 *C*1) or ipso Ph), 139.5 *vC *5)),
152.5 *vC*2)), 165.7*C4), 166.2 *CO ester), 189.0 *COexo).
3.2.3. *E)-*5-Ethoxycarbonylmethyl-4-oxothiazolidin-2-
ylidene)-N-*phenyl)-2-bromoethanamide *3b). The equi-
molar amount of Br2 as a 2% solution in dry alcohol was
added dropwise at room temperature to the suspension of
*Z)-1b *110 mg, 0.34 mmol) in 7mL of dry ethanol, with
stirring, over the period of 7±8 min whereupon the starting
compound dissolved. The resulting pale yellowish solution,
which became cloudy at the end of the Br2 addition, was
stirred for additional 20 min. Upon standing for several
hours pale yellowish crystals were precipitated, ®ltered,
washed with alcohol and dried to give *E)-3b 83 mg
*60%), mp 118±1208C; IR *KBr): n 3437, 3371, 3205,
3028, 2953, 2935, 1735, 1719, 1636, 1599, 1557, 1529,
3.2. Preparation of vinylbromides 3a±c
3.2.1. *Z)-*5-Ethoxycarbonylmethyl-4-oxothiazolidin-2-
ylidene)-N-*2-phenylethyl)-2-bromoethanamide
*3a).
The suspension of *Z)-1a *150 mg, 0.43 mmol) in 21 mL
of CCl4 was brought to re¯ux and equimolar amount of
Br2 as a 2% solution in CCl4 was added, with stirring,
over the period of 25 min whereas the starting compound
completely dissolved. The resulting nearly colorless solu-
tion was stirred for additional 15 min and then concentrated
under reduced pressure to about 2 mL. Pale yellowish crys-
tals were precipitated, ®ltered, washed with CCl4 and dried
to give *Z)-3a *121 mg, 66%), mp 113±1148C; IR *KBr): n
3374, 3169, 3145, 3023, 2986, 2948, 1719, 1608, 1584,
1524, 1376, 1347, 1312, 1302, 1229, 1191, 853, 749, 703,
1
1380, 1313, 1235, 1196, 812, 755, 689 cm21. H NMR
*CDCl3): d 1.27*3H, t, J7.0 Hz, CH3), 2.96 *1H, dd,
JAB17.5 Hz, JAX8.5 Hz, CHAHBCHXS), 3.13 *1H, dd,
JAB17.5 Hz, JBX4.0 Hz, CHAHBCHXS), 4.19 *2H, q,
J7.0 Hz, CH2O), 4.31 *1H, dd, JAX8.5 Hz,
JBX4.0 Hz, CHXS), 7.10±7.18 *1H, m, p-Ph), 7.26±7.38
*2H, m, m-Ph), 7.52±7.57 *2H, m, o-Ph), 8.01 *1H, s,
NHexo), 8.11 *1H, s, NHring); 13C NMR *CDCl3): d 14.1
*CH3), 37.3 *CH2COO), 44.3 *CHS), 61.6 *CH2O), 87.2
*vCBr), 120.1 *o-Ph), 124.9 *p-Ph), 129.1 *m-Ph), 137.3
*C*1)± Ph), 154.2 *Cv), 161.2 *COexo), 169.7*CO ring),
173.6 *COester). MS *CI) m/z 399/401 *M11); MS *EI) m/z
*rel. intensity) 398 *4)/400 *5) *M1), 397*12)/399 *13), 353
*7)/355 *4), 319 *100), 306 *9)/308 *8), 273 *30), 260 *13)/
262 *13), 245 *12), 232 *14)/234 *16), 231 *19), 206 *4)/208
*4),159 *5), 146 *3)/148 *3), 131 *7), 93 *85), 87 *6), 77 *9),
66 *3), 65 *2); UV *CHCl3): lmax *1) 308.0 nm *28.400).
Analytically pure sample 3b was isolated under the condi-
tions described above for vinyl bromide 3a using ethanol for
precipitation. Anal. Calcd for C15H15BrN2O4S: C, 45.12; H,
3.79; N, 7.02; S, 8.03. Found: C, 45.34; H, 4.01; N, 6.77; S,
7.85.
1
689 cm21; H NMR *CDCl3): d 1.28 *3H, t, J7.2 Hz,
CH3), 2.84 *1H, dd, JAB17.7 Hz, JAX10.2 Hz,
CHAHBCHXS) 2.85 *2H, t, J7.0 Hz, CH2Ph), 3.27*1H,
dd, JAB17.7 Hz, JBX3.4 Hz, CHAHBCHXS) 3.50±3.60
*2H, m, J7.0, 5.4 Hz, NHCH2CH2), 4.21 *2H, q,
J7.2 Hz, CH2O), 4.26 *1H, dd, JAX10.2 Hz,
JBX3.4 Hz, CHXS), 6.27*1H, t, J5.4 Hz, NHexo), 7.19±
7.39 *5H, m, Ph), 11.46 ppm *s, 1H, NHring); 13C NMR
*CDCl3): d 14.1 *CH3), 35.6 *CH2Ph), 37.7 *CH2COO)
41.4 *CH2N), 44.0 *CHS), 61.6 *CH2O), 85.3 *vCBr),
126.7* p-Ph), 128.8 *o- and m-Ph), 138.4 *C*1)± Ph),
151.4 *vC*2)), 163.1 *COexo), 170.2 *C*4)), 173.9 *COester);
MS *CI) m/z 427/429 *M11); MS *EI) m/z *rel. intensity)
426 *70)/428 *79) *M1), 381 *15)/383 *15), 347*27), 335
*10)/337*11), 306 *100)/308 *92), 260 *22)/262 *25), 259
*17), 243 *12), 232 *25)/234 *28), 228 *28), 226 *18), 206
*13)/208 *12), 120 *14), 105 *38), 104 *17), 103 *14), 91
*30), 87 *17), 77 *12), 67 *12); UV *CHCl3): lmax *1)
292.0 nm *26,100). Puri®cation by chromatography using
a gradient of pure toluene to pure EtOAc as eluent, followed
by concentration of the collected fractions and precipitation
by CCl4 gave analytically pure sample 3a. Anal. Calcd for
C17H19BrN2O4S: C, 47.78; H, 4.48; N, 6.56; S, 7.50. Found:
C, 48.14; H, 4.56; N, 6.33; S, 7.60.
3.2.4. *Z)-*5-Ethoxycarbonylmethyl-4-oxothiazolidin-2-
ylidene)-N-*phenyl)-2-bromoethanamide *3b). This
compound was isolated as a pure *Z)-isomer by column
chromatography on silica gel of the *Z)-3b and *E)-3b
mixture, using relatively nonpolar toluene/EtOAc solvent
gradient *100/0±50/50, v/v): mp 96±1008C; IR *KBr): n
3399, 3127, 3031, 3013, 2993, 2976, 2935, 2906, 1725,
1713, 1625, 1597, 1541, 1530, 1377, 1320, 1233, 1217,
1
764, 750, 691 cm21; H NMR *CDCl3): d 1.29 *3H, t,
J7.3 Hz, CH3), 2.88 *1H, dd, JAB17.8 Hz,
JAX10.2 Hz, CHAHBCHXS), 3.28 *1H, dd, JAB17.8 Hz,
JBX3.5 Hz, CHAHBCHXS), 4.22 *2H, q, J7.3 Hz, CH2O),
4.30 *1H, dd, JAX10.2 Hz, JBX3.5 Hz, CHXS), 7.05±7.13
*1H, m, p-Ph), 7.27±7.35 *2H, m, m-Ph), 7.58±7.63 *2H, m,
o-Ph), 7.96 *1H, s, NHexo), 11.42 *1H, s, NHring); 13C NMR
*CDCl3): d 14.1 *CH3), 37.6 *CH2COO), 44.1 *CHS), 61.7
*CH2O), 84.7* vCBr), 120.5 *o-Ph), 125.1 *p-Ph), 129.1
*m-Ph), 137.0 *C*1)± Ph), 153.1 *Cv), 161.4 *COexo),
170.2 *COring), 174.0 *COester).
3.2.2. *E)-*5-Ethoxycarbonylmethyl-4-oxothiazolidin-2-
ylidene)-N-*2-phenylethyl)-2-bromoethanamide
*3a).
This compound was obtained by isomerization of *Z)-3a
isomer in DMSO-d6 *10 days) giving rise to the equilibrated
40:60 mixture of the *Z)-3a and *E)-3a isomers. H NMR
1
*DMSO-d6) for 3a-E: d 1.18 *3H, t, J7.2 Hz, CH3), 2.74
*2H, t, J6.8 Hz, CH2Ph), 2.93 *1H, dd, JAX7.3 Hz,
CHAHBCHXS; due to the small chemical shift difference
of HA and HB protons the signal does not show typical
ABX pattern; thus JAB can't be determined), 3.12 *1H, dd,
3.2.5. *Z)-*5-Ethoxycarbonylmethyl-4-oxothiazolidin-2-
ylidene)-2-bromo-1-phenylethanone *3c). An equimolar